Dyax (DYAX) Gross Profit Margin starting from the third quarter 2015 to third quarter 2014, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Dyax Corp  (DYAX)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Dyax's Gross Profit Margin by quarter

Trends, Rankings, Statistics



DYAX Gross Profit Margin (Sep 30 2015)
Q3
(Jun 30 2015)
Q2
(Mar 31 2015)
Q1
(Dec 31 2014)
Q4
(Sep 30 2014)
Q3
Y / Y Revenue Change 12.44 %
Seq. Revenue Change -6.23 %
Revenue In Millions $24.73
Gross Profit Margin 85.59 %
Gross Profit Margin Total Ranking # 415
Gross Profit In Millions $21.17
Y / Y Gross Profit Change 4.48 %
Seq. Gross Profit Change -7 %


Commenting Third Quarter 2015 Gross Profit Margin
Dyax Corp experienced contraction in Gross Profit by -7 % to $25 millions and Revenue by -6.23 %, while Gross Profit Margin fell to 85.59 %, below company*s average Gross Profit Margin.


Observing third quarter 2015 results within Medical Laboratories industry only one other company has achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 415, from total ranking in the previous quarter at 425.
Learn about Gross Margin
DYAX's Gross Profit Margin third quarter 2015 Company Ranking
Within: No.
Medical Laboratories Industry # 2
Healthcare Sector # 48
Overall # 338

Gross Profit Margin Statistics
High Average Low
97.03 % 91.8 % 81.47 %
(Jun 30 2012)   (Mar 31 2015)




Other Gross Profit Margin Profitability Ratios
DYAX's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
DYAX's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for DYAX's Competitors
Gross Profit Margin Profit Margin for Dyax's Suppliers
Gross Profit Margin Profit Margin for DYAX's Customers

You may also want to know
DYAX's Annual Growth Rates DYAX's Profitability Ratios DYAX's Asset Turnover Ratio DYAX's Dividend Growth
DYAX's Roe DYAX's Valuation Ratios DYAX's Financial Strength Ratios DYAX's Gross Profit Growth
DYAX's Roa DYAX's Inventory Turnover Ratio DYAX's Growth Rates DYAX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2015, within Medical Laboratories Industry Gross Profit MarginSep 30 2015 MRQ Gross ProfitSep 30 2015 MRQ Revenue
Incyte Corporation  95.71 %$ 179.571  Millions$ 187.611  Millions
Dyax Corp  85.59 %$ 21.165  Millions$ 24.729  Millions
Icon Plc  83.74 %$ 330.540  Millions$ 394.741  Millions
Genomic Health Inc  81.35 %$ 59.836  Millions$ 73.554  Millions
Fulgent Genetics Inc   68.40 %$ 1.987  Millions$ 2.905  Millions
Caredx Inc   64.09 %$ 4.583  Millions$ 7.151  Millions
Cba Florida Inc   61.87 %$ 0.885  Millions$ 1.431  Millions
Syneos Health Inc   61.29 %$ 214.615  Millions$ 350.145  Millions
Advanced Container Technologies Inc   60.59 %$ 0.199  Millions$ 0.329  Millions
Charles River Laboratories International inc   58.46 %$ 204.300  Millions$ 349.465  Millions
Nrc Health  56.40 %$ 14.238  Millions$ 25.244  Millions
U s Stem Cell Inc   56.25 %$ 0.314  Millions$ 0.558  Millions
Veracyte Inc   54.45 %$ 6.717  Millions$ 12.335  Millions
Hologic Inc  53.98 %$ 379.400  Millions$ 702.800  Millions
Grapefruit Usa Inc   52.56 %$ 0.053  Millions$ 0.100  Millions
Iqvia Holdings Inc   52.06 %$ 741.711  Millions$ 1,424.769  Millions
Psychemedics Corporation  48.79 %$ 3.457  Millions$ 7.084  Millions
Pra Health Sciences Inc   47.26 %$ 190.702  Millions$ 403.510  Millions
Exact Sciences Corporation  40.41 %$ 5.104  Millions$ 12.632  Millions
Quest Diagnostics Inc  38.19 %$ 718.000  Millions$ 1,880.000  Millions
Capforce Inc   37.87 %$ 0.371  Millions$ 0.981  Millions
Luna Innovations Inc  37.71 %$ 4.979  Millions$ 13.205  Millions
American Shared Hospital Services  37.52 %$ 1.454  Millions$ 3.875  Millions
Labcorp Holdings Inc   33.61 %$ 762.900  Millions$ 2,269.900  Millions
Natera Inc   32.20 %$ 14.465  Millions$ 44.921  Millions
Inotiv Inc   25.98 %$ 1.293  Millions$ 4.977  Millions
Vyant Bio Inc   22.43 %$ 0.897  Millions$ 4.000  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.